ID   FU-RPNT-1
AC   CVCL_4837
SY   FU-PNET-1
DR   CLO; CLO_0050891
DR   BioSample; SAMN03473644
DR   FANTOM5_SSTAR; 10637-108I7
DR   RCB; RCB1495
DR   Wikidata; Q54835248
RX   PubMed=9559290;
RX   PubMed=27613543;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9559290).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1495
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=9559290; DOI=10.1097/00019606-199712000-00002;
RA   Takeuchi T., Iwasaki H., Ohjimi Y., Ohshima K.-i., Kaneko Y.,
RA   Ishiguro M., Hiratsuka Y., Sakamoto K., Kikuchi M.;
RT   "Renal primitive neuroectodermal tumor: a morphologic, cytogenetic,
RT   and molecular analysis with the establishment of two cultured cell
RT   lines.";
RL   Diagn. Mol. Pathol. 6:309-317(1997).
//
RX   PubMed=27613543; DOI=10.1007/s13577-016-0145-7;
RA   Ishiguro M., Yuki M., Fukushige T., Mizoguchi M., Kaneko Y.,
RA   Morishige T., Iwasaki H.;
RT   "Molecular cytogenetic characterization of two established ESFT cell
RT   lines.";
RL   Hum. Cell 30:41-48(2017).
//